Search clinical trials for: Phase 2b Dose-Ranging Study

Total 10000 results

Pfizer

Terminated

A Study Of The Analgesic (Pain-Relief) Effects Of Tanezumab In Adult Patients With Diabetic Peripheral Neuropathy

Diabetic Peripheral Neuropathy

United States
Vergent Bioscience, Inc.

Completed

Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung. (VISUALIZE)

Lung Cancer | Lung Metastases

United States, Australia
LimmaTech Biologics AG
Johns Hopkins Bloomberg School of Public Health

Completed

Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a

Shigellosis

United States
Deltanoid Pharmaceuticals

Completed

A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis (2MD-7H-2B)

Kidney Failure, Chronic | Hyperparathyroidism, Secondary

United States
BBB-Therapeutics B.V.

Completed

An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma.

Melanoma | Breast Cancer | Lung Cancer | Malignant Glioma | Brain Metastases

United States, Netherlands, France, Belgium

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe